However, the application of immunosuppressive therapy in peritoneal neoplasms is rarely reported, and it remains unclear how PD-1 and Tim-3 impact on the prognosis of peritoneal neoplasms. This evidence concerns the gene HAVCR2 and peritoneal neoplasm.